Academic Journal
Q1European Urology
About European Urology
European Urology is a scholarly journal published by Elsevier B.V.. SCImago 2025 places it in Q1 with an SJR of 8.715 and an H-index of 288.
Its listed coverage is 1975-2026 and its research categories include Urology (Q1). The 2025 dataset reports 384 documents and 7695 citations across the latest three-year reporting window.
European Urology: Advancing Global Urological Research and Practice
European Urology is one of the most prestigious and widely recognized peer-reviewed medical journals in the field of urology. Published by Elsevier and officially associated with the European Association of Urology (EAU), it plays a crucial role in advancing urological knowledge, research, and clinical practices across the globe. This influential journal is a go-to resource for urologists, researchers, and healthcare professionals seeking cutting-edge developments in the diagnosis, treatment, and prevention of urological conditions.
What is European Urology?
European Urology is an international monthly journal that covers a broad range of topics within the field of urology. These include urologic oncology, robotic and laparoscopic surgery, andrology, renal transplantation, urinary tract infections, and more. Since its inception, it has consistently published high-impact clinical studies, review articles, and expert guidelines that influence both clinical practice and academic research.
High Impact Factor and Global Reach
One of the defining features of European Urology is its high impact factor, which reflects the journal’s influence and credibility in the medical community. It consistently ranks among the top urology journals worldwide, making it an essential resource for those interested in evidence-based urological care. Its global readership includes practitioners, surgeons, residents, and academic researchers, contributing to the journal’s vast influence in shaping international urological standards.
Key Topics Covered
The journal covers a diverse array of subjects, such as:
-
Prostate Cancer and Bladder Cancer: Advances in early detection, screening, and treatment methods.
-
Minimally Invasive Surgery: Robotic and laparoscopic approaches in modern urological procedures.
-
Andrology and Male Health: Erectile dysfunction, fertility, and testosterone replacement therapies.
-
Urinary Tract Disorders: Innovations in the management of incontinence, infections, and kidney stones.
Why European Urology is Important
European Urology bridges the gap between research and practice, ensuring that the latest scientific advancements are translated into clinical settings. The journal also supports continuing medical education by offering access to the latest reviews, consensus statements, and guidelines from leading experts and institutions.
SEO Keywords and Relevance
If you're searching for trustworthy and up-to-date information on topics like “urological journals,” “European Association of Urology,” “prostate cancer research,” or “best journals in urology,” European Urology is the ideal reference point. Its reliable content and editorial standards make it a top-ranking result for medical professionals and patients alike
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Understanding the Scope of European Urology: Advancing Excellence in Urological Research and Practice
European Urology is one of the most prestigious peer-reviewed journals in the field of urology, globally recognized for publishing cutting-edge research and clinical studies. As the official journal of the European Association of Urology (EAU), European Urology plays a crucial role in shaping the future of urological science and clinical practice. Its scope encompasses a wide range of topics that reflect the dynamic and evolving nature of urology, making it a central resource for urologists, researchers, and healthcare professionals worldwide.
What Is the Scope of European Urology?
European Urology covers the entire spectrum of urological disciplines. Its broad scope includes:
-
Oncology: Research and clinical developments in prostate, bladder, kidney, and testicular cancers, with a focus on diagnostics, treatment protocols, and long-term outcomes.
-
Functional Urology: Studies on lower urinary tract symptoms (LUTS), urinary incontinence, neuro-urology, and pelvic floor dysfunction.
-
Urolithiasis and Endourology: Innovations in the treatment and prevention of kidney stones and advancements in minimally invasive surgical techniques.
-
Male Health and Andrology: Topics such as erectile dysfunction, male infertility, and testosterone deficiency syndromes.
-
Pediatric Urology: Congenital anomalies, developmental disorders, and surgical interventions in children.
-
Transplantation and Renal Function: Research focused on kidney transplantation, dialysis, and related renal diseases.
-
Innovative Therapies and Technologies: Robotics, artificial intelligence in diagnostics, and novel pharmacological treatments.
European Urology's Role in the Medical Community
The journal serves as a platform for disseminating high-quality scientific information, promoting evidence-based practices, and supporting continuous medical education. It publishes:
-
Original research articles
-
Systematic reviews and meta-analyses
-
Clinical guidelines
-
Editorials and commentaries
-
Case reports and letters to the editor
The journal is particularly valued for its rigorous peer-review process, which ensures the integrity and reliability of its content. European Urology’s impact factor and global citation rate further underscore its influence in academic and clinical settings.
Who Should Read European Urology?
European Urology is an essential resource for:
-
Urologists in clinical practice
-
Medical researchers and academics
-
Oncologists and radiologists
-
Surgical specialists
-
Medical students and residents in urology
-
Healthcare policy makers and hospital administrators
By staying up to date with the journal’s latest publications, professionals can enhance their knowledge, improve patient outcomes, and contribute to the advancement of urological science.
Recent Research Articles
Latest publications matched automatically by ISSN.
Re: Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial
Niyazi Volkan Demircan
2026-09 · DOI: 10.1016/j.eururo.2026.08.011Re: Perioperative enfortumab vedotin and pembrolizumab in bladder cancer
Giandomenico Roviello, Lorenzo Antonuzzo
2026-09 · DOI: 10.1016/j.eururo.2026.04.023Re: Kitamura et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection (JCOG1019). Eur Urol 2026. 2026;89:437–445
Spyridon P. Basourakos, Jonathan Shoag, Adam Calaway
2026-09 · DOI: 10.1016/j.eururo.2026.03.037EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer
Derya Tilki, Roderick C.N. van den Bergh, Erik Briers, Peter Chiu et al.
2026-09 · DOI: 10.1016/j.eururo.2026.04.014EAU–EANM–ESTRO–ESUR–ISUP–SIOG Guidelines on Prostate Cancer—2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent
Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, Peter Chiu et al.
2026-09 · DOI: 10.1016/j.eururo.2026.04.013Re: Gallagher et al. RESECT, A Randomised Controlled Trial of Audit and Feedback in Non–muscle-invasive Bladder Cancer Surgery. Eur Urol 2026. 2026;89:355–365
Francesco Di Bello, Andrea Gallioli, Pietro Diana, Giulio Avesani et al.
2026-09 · DOI: 10.1016/j.eururo.2026.03.040Reply to Paolo Zaurito, Giorgio Gandaglia, and Francesco Montorsi’s Letter to the Editor re: Daria Chernysheva, Francesco Di Bello, Giulio Avesani et al. ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.06.012
Daria Chernysheva, Francesco Di Bello, Giulio Avesani, Francesco Sanguedolce et al.
2026-09 · DOI: 10.1016/j.eururo.2026.08.009Diagnostic Accuracy of Circulating Tumor DNA to Predict Retroperitoneal Histology in Patients Treated With Retroperitoneal Lymph Node Dissection for Testicular Germ Tumor
Parth U. Thakker, Connor Drake, Jiping Zeng, Amy Tennant et al.
2026-09 · DOI: 10.1016/j.eururo.2026.03.018Re: Prevention of Urinary Stones with Hydration: A Randomised Clinical Trial of an Adherence Intervention
Gaëtan Devos, Carl Van Haute
2026-09 · DOI: 10.1016/j.eururo.2026.04.020Reply to Andrew R. A. Godtman et al.’s Letter to the Editor re: The PROSA Trial: Some Prosaic Comments. Eur Urol. 2026;90:e58–e59
Emanuele Messina, Antonella Borrelli, Valeria Panebianco
2026-09 · DOI: 10.1016/j.eururo.2026.06.010Re: Prevention of Urinary Stones with Hydration: A Randomised Clinical Trial of an Adherence Intervention
Daoyuan Li
2026-09 · DOI: 10.1016/j.eururo.2026.04.024Re: Personalizing Prostate Cancer Education for Patients Using an EHR-Integrated LLM Agent
Tiange Li, David-Dan Nguyen, Adree Khondker, Jethro C.C. Kwong et al.
2026-09 · DOI: 10.1016/j.eururo.2026.04.008Congress Calendar
2026-09 · DOI: 10.1016/j.eururo.2026.08.004Combining ctDNA and utDNA as a Dual Biomarker-driven Strategy for Bladder-sparing Therapy in Muscle-invasive Bladder Cancer: Neither Alone Is Sufficient
José Daniel Subiela, Daniel A. González-Padilla, Renate Pichler, Pietro Scilipoti et al.
2026-09 · DOI: 10.1016/j.eururo.2026.04.030The PROSA trial: Some Prosaic Comments
Rebecka Arnsrud Godtman, Jonas Wallström, Ola Bratt
2026-09 · DOI: 10.1016/j.eururo.2026.03.036Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform
Struan Gray, Peter Dutey-Magni, Craig Jones, Laura R. Murphy et al.
2026-09 · DOI: 10.1016/j.eururo.2026.08.012Open Versus Robot-assisted Kidney Transplantation in Adults with End-stage Kidney Disease (ORAKTx): A Randomised Open-label Trial
Milla Ortved, Julia Dagnæs-Hansen, Hein V. Stroomberg, Camilla Vejlstrup et al.
2026-09 · DOI: 10.1016/j.eururo.2026.04.022European Association of Urology Guidelines on Neuro-urology: Summary of the 2026 Update
Andrea M. Sartori, Thomas M. Kessler, Hazel Ecclestone, Dennis Frings et al.
2026-09 · DOI: 10.1016/j.eururo.2026.04.012Re: Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer
Javier Molina-Cerrillo, Teresa Alonso-Gordoa
2026-09 · DOI: 10.1016/j.eururo.2026.04.007Sutureless Purely Off-clamp Robotic Partial Nephrectomy: Evidence from a Randomized Controlled Noninferiority Trial
Aldo Brassetti, Gabriele Tuderti, Umberto Anceschi, Alfredo Maria Bove et al.
2026-09 · DOI: 10.1016/j.eururo.2026.04.019Reviews
Community Reviews
Version History
April 19, 2025 at 4:49 pm
April 19, 2025